Medical School · Year 2 · Immunology · includes a quiz and discussion video

Lecture 2: Adaptive Immunity Overview

Unit 2.7: Immunology

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the key features of adaptive immunity
2. Explain the lymphoid organs and lymphocyte development
3. Describe the structure and diversity of antigen receptors
4. Explain the principles of clonal selection and expansion
5. Describe the types of adaptive immune responses
6. Explain immunological memory and its clinical significance

Lecture Outline

I. Features of Adaptive Immunity

The adaptive immune system represents an evolutionary innovation unique to jawed vertebrates, providing highly specific recognition of virtually any molecular structure and the capacity to remember previous encounters for enhanced future responses. Unlike innate immunity, which relies on germline-encoded receptors recognizing conserved microbial patterns, adaptive immunity generates an enormous diversity of antigen receptors through somatic gene rearrangement, ensuring that at least some lymphocytes can recognize any potential pathogen. This anticipatory repertoire enables the immune system to respond to novel pathogens, including those that evolve rapidly or have never been encountered by the species.

The cardinal features of adaptive immunity include specificity, diversity, memory, and self-tolerance. Specificity refers to the ability of each lymphocyte to recognize a single antigenic determinant (epitope) through its unique receptor, ensuring that immune responses are directed against the pathogen rather than innocent bystanders. Diversity describes the vast repertoire of antigen receptors generated through gene rearrangement, with estimates exceeding 10^11 possible unique receptors. Memory enables faster and more robust responses upon re-exposure to previously encountered antigens, forming the basis for vaccination. Self-tolerance, established during lymphocyte development and maintained in the periphery, prevents immune responses against the body's own tissues.

Adaptive immunity operates through two major effector arms that specialize in eliminating different types of pathogens. Humoral immunity, mediated by B cells and their secreted antibodies, targets extracellular pathogens and toxins through neutralization, opsonization, and complement activation. Cell-mediated immunity, orchestrated by T cells, addresses intracellular pathogens by either directly killing infected cells (CD8+ cytotoxic T cells) or activating other immune cells (CD4+ helper T cells). These two arms frequently cooperate, with CD4+ T cells providing essential help for B cell antibody production, linking the humoral and cellular responses.

The timeline of adaptive immune responses differs fundamentally from innate immunity. Primary responses to a new antigen require 1-2 weeks to develop, during which antigen-specific lymphocytes must be activated, undergo clonal expansion, and differentiate into effector cells. This lag phase explains why innate immunity is essential for early pathogen control. However, memory cells generated during primary responses enable secondary responses within 1-3 days, with higher magnitude and greater efficiency. This accelerated secondary response typically eliminates pathogens before they cause significant disease, providing the protection conferred by prior infection or vaccination.

<image> Panel A: Comparison diagram showing adaptive immunity features - specificity (one lymphocyte recognizing one epitope), diversity (10^11+ receptors generated by V(D)J recombination), memory (primary slow response becoming rapid secondary response), and self-tolerance (deletion of self-reactive cells during development) Panel B: Timeline graph comparing innate and adaptive immune responses showing innate response peak at 0-4 hours, primary adaptive response at 1-2 weeks with IgM predominance, and secondary response at 1-3 days with IgG predominance and higher magnitude Panel C: Schematic illustrating the two arms of adaptive immunity - humoral (B cells secreting antibodies targeting extracellular pathogens) and cell-mediated (CD8+ CTLs killing infected cells, CD4+ Th cells activating macrophages), with arrows showing cooperation between arms Panel D: Evolution diagram showing adaptive immunity appearing in jawed vertebrates approximately 500 million years ago, with key components (RAG genes, MHC, TCR/BCR) arising and enabling antigen receptor diversity </image>

II. Lymphoid Organs

Primary lymphoid organs serve as sites where lymphocytes develop from precursor cells and undergo the selection processes that shape the mature repertoire. The bone marrow functions as the primary lymphoid organ for B cells, providing the stromal cells, growth factors (IL-7), and microenvironment necessary for B cell development from hematopoietic stem cells. B cells complete their development entirely within the bone marrow, progressing through pro-B, pre-B, immature, and transitional stages before exiting as mature naive B cells. The bone marrow also generates T cell progenitors, which migrate to the thymus for further development.

The thymus is the primary lymphoid organ for T cell development, providing a unique microenvironment that supports T cell receptor gene rearrangement and the critical selection processes that establish self-tolerance. Located in the mediastinum, the thymus is most active during childhood and gradually involutes with age, though it retains some function throughout life. Thymic epithelial cells in the cortex present self-MHC molecules for positive selection, while medullary epithelial cells express tissue-restricted antigens under AIRE (autoimmune regulator) control for negative selection. T cells that successfully complete selection exit as CD4+ or CD8+ single-positive cells.

Secondary lymphoid organs are specialized tissues where mature lymphocytes encounter antigens and initiate adaptive immune responses. Lymph nodes, distributed throughout the body along lymphatic vessels, filter lymph draining from peripheral tissues and concentrate antigens for presentation to lymphocytes. Their organized architecture separates B cell areas (cortical follicles) from T cell areas (paracortex), with specialized vasculature (high endothelial venules) allowing lymphocyte entry from blood. The spleen similarly filters blood, with the white pulp serving as the lymphoid compartment containing periarteriolar lymphoid sheaths (T cells) and follicles (B cells).

Mucosa-associated lymphoid tissue (MALT) provides immune surveillance at mucosal surfaces where pathogen exposure is frequent. This includes gut-associated lymphoid tissue (GALT) such as Peyer's patches, tonsils, and adenoids, as well as bronchus-associated lymphoid tissue (BALT) and other mucosal sites. These tissues feature specialized epithelium with M cells that sample luminal antigens and deliver them to underlying immune cells. The organization of MALT enables rapid local immune responses and preferential generation of IgA-producing plasma cells that provide mucosal protection.

<image> Panel A: Diagram of primary lymphoid organs showing bone marrow cross-section with B cell developmental stages (pro-B, pre-B, immature B) in hematopoietic cords, and thymus with cortical positive selection and medullary negative selection zones containing epithelial cell networks Panel B: Lymph node architecture showing afferent lymphatics bringing antigen, cortical B cell follicles with germinal centers, paracortical T cell zones, medullary cords with plasma cells, and efferent lymphatics, with high endothelial venule allowing lymphocyte entry Panel C: Spleen white pulp organization showing central arteriole surrounded by periarteriolar lymphoid sheath (PALS) containing T cells, marginal zone, and B cell follicles, with blood filtration through red pulp sinusoids Panel D: GALT structure in Peyer's patch showing dome epithelium with M cells sampling luminal antigens, underlying B cell follicles with germinal centers, and T cell zones, with IgA+ plasma cells migrating to lamina propria </image>

III. Lymphocyte Development

B cell development occurs entirely within the bone marrow, proceeding through defined stages characterized by progressive immunoglobulin gene rearrangement. The earliest committed B cell progenitor (pro-B cell) initiates heavy chain gene rearrangement, first joining D and J segments, then V to the DJ unit. Successful productive rearrangement of one heavy chain allele triggers allelic exclusion, preventing rearrangement of the second allele and ensuring each B cell expresses only one specificity. The pre-B cell stage is defined by expression of the pre-B cell receptor, comprising the μ heavy chain paired with surrogate light chain components (VpreB and λ5), which signals for proliferation and light chain rearrangement.

Light chain rearrangement at the pre-B to immature B cell transition follows a similar pattern, with V-J joining generating the complete light chain gene. Light chains lack D segments, simplifying the rearrangement process. The κ locus rearranges first, and only if κ rearrangement fails on both alleles does λ rearrangement proceed, resulting in isotype exclusion (each B cell expresses either κ or λ, not both). Successful light chain rearrangement allows surface expression of complete IgM, marking the immature B cell stage where central tolerance mechanisms test for self-reactivity.

T cell development in the thymus follows a parallel logic with distinct details. Early thymocytes (double-negative, lacking both CD4 and CD8) undergo TCR β chain rearrangement, with successful rearrangement triggering β-selection and progression to the double-positive stage (expressing both CD4 and CD8). TCR α chain rearrangement then occurs, generating the complete αβ TCR. Unlike B cells, T cells do not undergo somatic hypermutation, so the TCR remains unchanged throughout the cell's life. The unique feature of T cell development is thymic selection, which eliminates both non-functional receptors (death by neglect) and self-reactive receptors (negative selection) while rescuing cells with appropriate self-MHC recognition (positive selection).

Central tolerance mechanisms during lymphocyte development eliminate or inactivate strongly self-reactive cells before they enter the peripheral repertoire. For B cells, this involves receptor editing (continued light chain rearrangement to change specificity), clonal deletion (apoptosis), and anergy (functional inactivation). For T cells, negative selection in the thymic medulla deletes cells recognizing self-antigens presented on AIRE-expressing epithelial cells. Some self-reactive T cells differentiate into regulatory T cells rather than undergoing deletion, providing an additional tolerance mechanism. These central tolerance processes are not perfect, necessitating peripheral tolerance mechanisms to control self-reactive cells that escape to the periphery.

<image> Panel A: B cell development stages in bone marrow showing pro-B (D-J then V-DJ heavy chain rearrangement), pre-B (pre-BCR expression, surrogate light chain), immature B (light chain rearrangement, surface IgM), with checkpoints and allelic exclusion indicated at each transition Panel B: V(D)J recombination mechanism showing germline heavy chain locus with V, D, and J segments, RAG1/2-mediated recombination signal sequence recognition, D-J joining followed by V-DJ joining, with N-nucleotide addition by TdT at junctions creating diversity Panel C: T cell developmental stages in thymus showing DN (double-negative, TCRβ rearrangement, β-selection checkpoint), DP (double-positive, TCRα rearrangement), positive selection in cortex, negative selection in medulla, and SP (single-positive CD4 or CD8) exit Panel D: Central tolerance mechanisms showing B cell options (receptor editing changing light chain, deletion, anergy) and T cell options (negative selection deleting high-affinity self-reactive cells, Treg development as alternative fate), with surviving cells entering peripheral repertoire </image>

IV. Antigen Receptor Structure

The B cell receptor (BCR) for antigen is membrane-bound immunoglobulin that can also be secreted as antibody upon B cell activation. The basic immunoglobulin structure consists of two identical heavy chains and two identical light chains linked by disulfide bonds, forming a Y-shaped molecule with two antigen-binding sites. Each chain contains variable (V) regions at the N-terminus that form the antigen-binding site and constant (C) regions toward the C-terminus that mediate effector functions. The variable regions contain three hypervariable loops called complementarity-determining regions (CDRs), with CDR3 being most diverse due to its location at the V(D)J junction.

The heavy chain constant region determines the antibody class (isotype): IgM, IgD, IgG, IgA, or IgE, each with distinct effector functions and tissue distributions. Mature naive B cells express both IgM and IgD through alternative splicing of the same VDJ-rearranged gene. Upon activation, B cells can undergo class switch recombination, replacing the constant region while maintaining the same variable region and antigen specificity. This allows the immune system to apply different effector functions to the same antigenic target depending on the nature of the immune challenge.

The T cell receptor (TCR) shares structural homology with immunoglobulin but has critical functional differences. Most T cells express αβ TCRs, consisting of α and β chains each with variable and constant domains. Unlike BCR, TCR does not have a secreted form and recognizes antigen only in the context of MHC molecules (MHC restriction). The TCR variable region also contains CDR loops, with CDR1 and CDR2 primarily contacting the MHC molecule and CDR3 primarily contacting the peptide. TCR signaling requires the associated CD3 complex (γ, δ, ε, and ζ chains), which contains immunoreceptor tyrosine-based activation motifs (ITAMs) that initiate downstream signaling.

Antigen receptor diversity is generated through several mechanisms during lymphocyte development. Combinatorial diversity arises from random selection of V, D, and J gene segments (or V and J for light chains and TCR α). Junctional diversity results from imprecise joining of gene segments and addition of non-templated (N) nucleotides by terminal deoxynucleotidyl transferase (TdT). Combinatorial association of heavy and light chains (or α and β chains) further multiplies diversity. For B cells only, somatic hypermutation during germinal center reactions introduces point mutations throughout the variable region, enabling affinity maturation. These mechanisms generate receptor diversity exceeding 10^11 unique specificities, ensuring coverage of virtually any potential antigen.

<image> Panel A: Immunoglobulin structure showing Y-shaped molecule with two heavy and two light chains, labeled domains (VH, CH1, CH2, CH3, VL, CL), hinge region providing flexibility, Fab fragments containing antigen-binding sites, and Fc fragment mediating effector functions, with disulfide bonds indicated Panel B: Comparison of BCR and TCR structures showing BCR (heavy + light chains, bivalent, recognizes native antigen, can be secreted) and TCR (α + β chains, monovalent, recognizes peptide-MHC, always membrane-bound), with signaling molecules (Igα/Igβ for BCR, CD3 complex for TCR) Panel C: Antigen-binding site detail showing CDR loops (CDR1, CDR2, CDR3) from both V regions forming the combining site, with CDR3 highlighted as most variable region spanning V(D)J junction, and antigen (epitope) fitting into binding pocket Panel D: Sources of antigen receptor diversity illustrated: combinatorial (V, D, J segment selection), junctional (imprecise joining, N-nucleotide addition), chain pairing (H×L or α×β combinations), and somatic hypermutation (B cells only, point mutations for affinity maturation) </image>

V. Clonal Selection and Expansion

The clonal selection theory, first proposed by Burnet, provides the conceptual framework for understanding adaptive immune responses. This theory posits that each lymphocyte bears receptors of a single specificity, generated before any antigen encounter. The encounter with antigen selects specific clones bearing complementary receptors, triggering their activation and proliferation. This clonal expansion amplifies the antigen-specific population, with some progeny differentiating into effector cells that eliminate the pathogen and others becoming long-lived memory cells that persist for future encounters.

Lymphocyte activation requires recognition of antigen through the clonally distributed receptor, but this signal alone is typically insufficient for full activation. The two-signal model describes how lymphocytes integrate antigen recognition (Signal 1) with additional signals (Signal 2) to distinguish genuine threats from harmless environmental antigens or self-components. For T cells, Signal 2 comprises costimulatory signals, particularly CD28 engagement by CD80/CD86 on activated antigen-presenting cells. Antigen recognition without costimulation leads to anergy (functional unresponsiveness), providing a peripheral tolerance mechanism. B cells similarly require second signals, typically provided by helper T cells through CD40 ligand-CD40 interaction.

Following activation, lymphocytes undergo massive clonal expansion, with individual cells dividing every 6-8 hours for several days. This exponential proliferation can increase the antigen-specific population by several orders of magnitude, generating the large numbers of effector cells needed to eliminate infection. During expansion, lymphocytes also differentiate into effector populations: B cells become antibody-secreting plasma cells, CD4+ T cells differentiate into helper subsets (Th1, Th2, Th17, Tfh), and CD8+ T cells become cytotoxic effectors. This differentiation is directed by cytokines (Signal 3), with different cytokine environments promoting different effector fates.

After pathogen clearance, the majority of effector cells die through apoptosis during the contraction phase, preventing immunopathology from excessive immune activity. However, a subset of cells survives as memory cells, remaining quiescent but capable of rapid reactivation upon antigen re-encounter. Memory cells differ from naive cells in several important ways: they are more numerous (expanded clone), have lower activation thresholds, respond faster, and include populations residing in peripheral tissues near potential infection sites. These differences underlie the enhanced secondary response that provides protection against subsequent infection with the same pathogen.

<image> Panel A: Clonal selection diagram showing diverse naive lymphocyte repertoire, antigen selecting specific clones with complementary receptors, clonal expansion of selected cells, differentiation into effector and memory populations, and pathogen elimination followed by contraction Panel B: Two-signal model for T cell activation showing Signal 1 (TCR-peptide/MHC), Signal 2 (CD28-CD80/86 costimulation), and outcomes: both signals leading to activation, Signal 1 alone leading to anergy, neither signal resulting in ignorance Panel C: Clonal expansion kinetics graph showing initial naive cell population, exponential expansion phase (doubling every 6-8 hours), peak effector response, contraction phase (most cells dying), and residual memory population, spanning primary immune response timeline Panel D: Differentiation pathways during immune response showing activated B cells becoming plasma cells (antibody secretion) or memory B cells, activated CD4+ T cells becoming Th1, Th2, Th17, or Tfh effectors under different cytokine influences, and activated CD8+ T cells becoming CTLs or memory CD8+ cells </image>

VI. Types of Adaptive Responses

Humoral immunity comprises the antibody-mediated component of adaptive immunity, providing defense against extracellular pathogens and toxins. B cells activated by antigen and helper T cell signals differentiate into plasma cells that secrete large quantities of antibody (up to 10^9 molecules per cell per day). These antibodies circulate in plasma and diffuse into tissues where they exert protective effects through several mechanisms. Neutralization prevents pathogen attachment to host cells or toxin binding to cellular receptors. Opsonization coats pathogens with antibody, enhancing phagocyte recognition through Fc receptors. Antibodies also activate complement through the classical pathway, leading to further opsonization, direct lysis, and inflammation.

Cell-mediated immunity encompasses T cell-dependent responses that do not involve antibody. CD4+ helper T cells (Th cells) orchestrate immune responses by recognizing peptide-MHC class II complexes on antigen-presenting cells and providing help to other immune cells through cytokine secretion and contact-dependent signals. Different Th subsets are specialized for different types of pathogens: Th1 cells producing IFN-γ activate macrophages against intracellular bacteria and protozoa; Th2 cells producing IL-4, IL-5, and IL-13 promote responses against helminths and mediate allergic inflammation; Th17 cells producing IL-17 recruit neutrophils against extracellular bacteria and fungi. T follicular helper (Tfh) cells provide help to B cells in germinal centers, driving antibody responses.

CD8+ cytotoxic T lymphocytes (CTLs) directly kill infected cells displaying foreign peptides on MHC class I molecules, representing the primary defense against intracellular pathogens that replicate in the cytoplasm. CTL killing mechanisms include perforin-mediated delivery of granzymes that induce apoptosis, and Fas ligand engagement of Fas on target cells. This cytotoxic activity requires prior activation and differentiation, typically with help from CD4+ T cells through a process called licensing, where Th cells activate dendritic cells to optimally prime CTL responses. CTLs are particularly important for controlling viral infections and contribute to tumor surveillance.

The type of adaptive response generated depends on the nature of the pathogen and the signals provided by innate immunity. Intracellular pathogens that stimulate IL-12 production by dendritic cells promote Th1 and CTL responses. Helminths promote Th2 responses through mechanisms involving IL-4 and basophil activation. Extracellular bacteria and fungi promote Th17 responses through IL-6 and IL-23. This functional specialization ensures that the effector mechanisms employed are appropriate for the pathogen type, while inappropriate responses (such as Th2 responses to bacteria) can be ineffective or harmful.

<image> Panel A: Humoral immunity overview showing B cell activation by antigen and T cell help, plasma cell differentiation and antibody secretion, and antibody effector functions - neutralization (blocking receptor binding), opsonization (enhancing phagocytosis), and complement activation (C1q binding to Fc) Panel B: CD4+ T helper subset functions showing Th1 (IFN-γ, macrophage activation, intracellular bacteria), Th2 (IL-4/IL-5/IL-13, eosinophils, IgE, helminths), Th17 (IL-17, neutrophil recruitment, extracellular bacteria/fungi), and Tfh (IL-21, germinal center B cell help) Panel C: CTL killing mechanism showing CD8+ T cell recognizing infected cell via peptide-MHC I, immunological synapse formation, directed granule release with perforin pore formation, granzyme B entry and caspase activation, and target cell apoptosis Panel D: Integration of adaptive response types with pathogen location showing extracellular bacteria (antibody, Th17-neutrophil), intracellular bacteria in macrophages (Th1-macrophage activation), cytoplasmic viruses (CTL killing), and parasites/helminths (Th2-eosinophil, IgE) </image>

VII. Primary vs Secondary Response

The primary immune response occurs upon first encounter with an antigen and displays characteristic kinetics reflecting the need to activate rare antigen-specific cells. Following antigen exposure, there is a lag phase of 5-10 days during which antigen-specific lymphocytes are activated, expanded, and differentiated before effector functions become apparent. For humoral responses, antibody first becomes detectable around day 7, peaks at 2-3 weeks, and gradually declines thereafter. The antibody produced during primary responses is predominantly IgM, as class switching to other isotypes requires germinal center reactions that take time to establish. Antibody affinity is relatively low initially but increases as germinal center reactions select for higher-affinity B cell clones.

The secondary response to the same antigen differs dramatically from the primary response in kinetics, magnitude, and quality. Memory cells generated during the primary response persist at higher frequencies than naive precursors and can be activated more rapidly due to lower threshold requirements. As a result, the lag phase is shortened to 1-3 days, and effector responses peak earlier. The magnitude of secondary responses typically exceeds primary responses by 10-100-fold, reflecting both the larger starting population of antigen-specific cells and their enhanced proliferative capacity. Memory B cells have already undergone class switching, so secondary antibody responses are dominated by IgG (or IgA at mucosal sites), with significantly higher affinity due to prior affinity maturation.

The molecular basis for memory cell properties involves both increased cell numbers and qualitative changes in the cells themselves. Memory lymphocytes have altered transcriptional programs that poise them for rapid effector function, including epigenetic modifications that facilitate gene expression upon activation. Memory cells express different surface molecules that affect their trafficking and activation requirements. Memory B cells express high-affinity, class-switched BCRs and can rapidly differentiate into antibody-secreting cells. Memory T cells include populations with different homing properties: central memory cells (Tcm) recirculate through lymphoid organs, while effector memory cells (Tem) and tissue-resident memory cells (Trm) patrol peripheral tissues.

The clinical significance of these response differences underlies vaccination strategies. Vaccines expose the immune system to pathogen antigens in a controlled manner, generating memory without causing disease. Upon subsequent natural infection, the memory response provides rapid protection before the pathogen can establish significant infection. Booster vaccinations reactivate memory responses, enhancing their magnitude and longevity. Understanding response kinetics also informs diagnostic serology: detection of IgM suggests recent or acute infection (primary response), while IgG indicates prior exposure or immunization (secondary response or post-primary phase).

<image> Panel A: Graph comparing primary and secondary antibody response kinetics, showing primary response with 1-2 week lag, IgM predominance, lower peak antibody levels; and secondary response with 1-3 day lag, IgG predominance, higher peak levels, and sustained response Panel B: Cellular basis for enhanced secondary response showing larger antigen-specific cell population after primary response, lower activation threshold of memory cells compared to naive cells, and faster proliferation and differentiation kinetics Panel C: Qualitative differences between primary and secondary antibody showing IgM (pentameric, low affinity) in primary response versus IgG (monomeric, high affinity due to somatic hypermutation and affinity maturation) in secondary response, with germinal center role highlighted Panel D: Clinical applications showing vaccination timeline with prime immunization generating memory, booster immunization expanding memory, and natural infection triggering rapid protective secondary response; plus serology interpretation (IgM = acute, IgG = prior exposure) </image>

VIII. Immunological Memory

Immunological memory represents the ability of the adaptive immune system to "remember" previously encountered antigens and mount enhanced responses upon re-exposure. This memory is mediated by long-lived memory lymphocytes that persist after the primary response has resolved, surviving for years to decades in the absence of persistent antigen. Memory cells occupy distinct niches in the body, with some circulating between blood and lymphoid organs while others reside permanently in peripheral tissues at likely sites of pathogen re-entry. The persistence and strategic positioning of memory cells ensures that secondary responses can be initiated rapidly at the site of infection.

Memory B cells differ from naive B cells in several important respects that enable their enhanced function. They express class-switched, high-affinity BCRs resulting from somatic hypermutation and selection in germinal centers. Upon re-activation, memory B cells can rapidly differentiate into antibody-secreting cells without requiring a germinal center response, though some will enter germinal centers for further affinity maturation. Long-lived plasma cells, residing primarily in bone marrow niches, continuously secrete antibody and provide immediate humoral protection without requiring reactivation. These plasma cells can survive for decades, maintaining protective antibody levels throughout life.

Memory T cells exist in several functionally distinct populations defined by surface marker expression and tissue localization. Central memory T cells (Tcm) express lymph node homing receptors (CCR7, CD62L) and recirculate through secondary lymphoid organs where they can be activated by dendritic cells presenting antigen. Effector memory T cells (Tem) lack these homing receptors and instead patrol peripheral tissues and blood, providing rapid effector function at infection sites. Tissue-resident memory T cells (Trm) permanently reside in barrier tissues (skin, gut, lung) where they provide frontline defense without requiring recruitment from circulation. Stem cell memory T cells (Tscm) represent a recently characterized population with exceptional longevity and self-renewal capacity.

Memory maintenance depends on homeostatic signals rather than continuous antigen stimulation. Memory lymphocytes express receptors for homeostatic cytokines, particularly IL-7 and IL-15, which promote survival and occasional homeostatic proliferation. These signals maintain memory populations at relatively constant levels for extended periods. Importantly, memory cells can persist after antigen is completely cleared, distinguishing immunological memory from chronic antigen exposure. However, memory does wane over time, particularly for T cells, explaining why booster vaccinations are needed to maintain protective immunity against some pathogens. Cross-reactive antigens from environmental exposures or unrelated infections may help maintain memory to some pathogens.

<image> Panel A: Memory B cell characteristics showing class-switched high-affinity BCR, rapid plasma cell differentiation upon re-activation, and comparison with long-lived plasma cells in bone marrow niches continuously secreting antibody without activation requirement Panel B: Memory T cell subsets diagram showing Tcm (CCR7+CD62L+, lymph node recirculation), Tem (CCR7-CD62L-, peripheral tissue patrol), Trm (CD69+CD103+, tissue-resident barrier defense), and Tscm (CD45RA+, stem-like properties), with locations and functions Panel C: Memory maintenance mechanisms showing homeostatic cytokine receptors (IL-7R, IL-15R) on memory cells, cytokine-driven survival and occasional proliferation, comparison of naive cell dependence on antigen versus memory cell independence, and gradual waning over time Panel D: Functional comparison of naive versus memory lymphocytes in table format showing cell frequency (rare vs expanded), activation threshold (high vs low), response time (days vs hours), effector function (requires differentiation vs rapid), and lifespan (weeks vs years) </image>

IX. Antigens and Epitopes

An antigen is any substance capable of being specifically recognized by components of the adaptive immune system, while an immunogen is an antigen capable of inducing an immune response. This distinction is important because some small molecules (haptens) can be recognized by antibodies but cannot independently stimulate immune responses. Haptens become immunogenic when coupled to larger carrier proteins that provide T cell epitopes. Natural antigens are typically proteins, polysaccharides, lipids, or nucleic acids, with proteins being the most immunogenic due to their structural complexity and ability to provide both B cell and T cell epitopes.

Epitopes are the specific portions of antigens recognized by lymphocyte receptors. B cell epitopes, recognized by antibodies and BCRs, are determined by the three-dimensional structure of the antigen and may be continuous (linear sequence of amino acids) or discontinuous (amino acids brought together by protein folding). B cell epitopes typically span 15-25 amino acids and are located on the accessible surface of antigens. T cell epitopes, recognized by TCRs, are short peptides (8-10 amino acids for MHC class I, 13-25 amino acids for MHC class II) that result from intracellular antigen processing. The same protein antigen therefore presents different epitopes to B cells (surface features of native protein) and T cells (internal peptide sequences displayed on MHC).

Several factors influence the immunogenicity of an antigen. Foreignness is paramount—molecules similar to self are poorly immunogenic due to tolerance mechanisms. Larger molecules are generally more immunogenic because they contain more potential epitopes. Chemical complexity (particularly the presence of aromatic amino acids) enhances immunogenicity. The route of administration affects the immune response type, with subcutaneous injection favoring systemic responses and mucosal administration favoring local IgA responses. Adjuvants are substances that enhance immunogenicity, typically by activating innate immune responses that provide the costimulatory signals and cytokines necessary for adaptive immunity.

Superantigens represent a special category of molecules that activate T cells through a mechanism distinct from conventional antigen recognition. Instead of being processed into peptides, superantigens bind simultaneously to MHC class II molecules (outside the peptide-binding groove) and TCR β chains (outside the normal peptide-MHC contact site). This binding activates all T cells expressing particular Vβ regions regardless of their peptide specificity, potentially activating up to 20% of T cells compared to the 0.0001% activated by conventional antigens. The massive cytokine release resulting from this polyclonal activation causes toxic shock syndrome, as seen with staphylococcal enterotoxins and streptococcal pyrogenic exotoxins.

<image> Panel A: Antigen-epitope relationship showing protein antigen with multiple B cell epitopes on surface (both continuous/linear and discontinuous/conformational) and internal sequences that become T cell epitopes after processing, with antibody and TCR recognition indicated Panel B: Hapten-carrier conjugate showing small hapten molecule unable to stimulate response alone, carrier protein providing T cell epitopes, conjugate eliciting antibody response against hapten with T cell help directed against carrier epitopes Panel C: Factors affecting immunogenicity displayed as scales or meters: foreignness (more different from self = more immunogenic), molecular weight (larger = more epitopes), complexity (more chemical diversity = more immunogenic), with adjuvant effects enhancing all parameters Panel D: Superantigen mechanism showing SAg bridging MHC class II on APC and TCR Vβ region on T cell without normal peptide processing, comparison of conventional antigen activating 0.0001% versus superantigen activating up to 20% of T cells, and resulting cytokine storm </image>

X. Immune Regulation

Peripheral tolerance mechanisms complement central tolerance in preventing autoimmune responses by controlling self-reactive lymphocytes that escape deletion during development. Anergy represents functional inactivation of lymphocytes that recognize antigen without receiving appropriate costimulatory signals, as occurs when self-antigens are presented by tissue cells lacking costimulatory molecules. Anergic cells remain alive but unresponsive to antigen restimulation. Activation-induced cell death (AICD) eliminates repeatedly stimulated lymphocytes through Fas-mediated apoptosis, limiting immune responses and preventing chronic activation by persistent self-antigens. Ignorance refers to the failure of lymphocytes to respond to antigens in immunologically privileged sites (such as the eye, brain, and testis) that are sequestered from immune surveillance.

Regulatory T cells (Tregs) actively suppress immune responses through multiple mechanisms, representing a dominant form of peripheral tolerance. Natural Tregs develop in the thymus from self-reactive thymocytes that receive intermediate-strength signals, while induced Tregs (iTregs) differentiate in the periphery from conventional CD4+ T cells under the influence of TGF-β. Both populations express the transcription factor Foxp3, which is essential for their development and function. Treg suppressive mechanisms include secretion of inhibitory cytokines (IL-10, TGF-β), CTLA-4-mediated inhibition of costimulation, metabolic disruption (IL-2 consumption, adenosine production), and direct cytotoxicity through granzyme/perforin.

Immune checkpoints are inhibitory pathways that physiologically limit immune responses and are exploited therapeutically in cancer immunotherapy. CTLA-4 (CD152) competes with CD28 for binding to CD80/CD86, delivering inhibitory signals and removing costimulatory molecules from APC surfaces through trans-endocytosis. PD-1 (CD279), expressed on activated T cells, binds PD-L1 and PD-L2 on target cells and APCs, inhibiting T cell effector functions. These checkpoints normally prevent excessive immune responses and autoimmunity, but tumors exploit them to evade immune attack. Checkpoint inhibitor antibodies (anti-CTLA-4, anti-PD-1) release these brakes, enhancing antitumor immunity at the cost of increased autoimmune complications.

IPEX syndrome (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked) dramatically illustrates the importance of Tregs in maintaining immune homeostasis. This rare condition results from mutations in FOXP3, the gene encoding the Treg master transcription factor. Affected males present in infancy with severe autoimmune manifestations including enteropathy, type 1 diabetes, thyroiditis, and dermatitis. Without functional Tregs, self-reactive lymphocytes that normally would be suppressed cause widespread tissue destruction. IPEX requires immunosuppressive treatment and potentially hematopoietic stem cell transplantation for definitive therapy. The severity of IPEX underscores that tolerance is an active process requiring continuous Treg activity, not simply the absence of self-reactive cells.

<image> Panel A: Peripheral tolerance mechanisms showing anergy (antigen recognition without costimulation leading to unresponsive state), AICD (repeated activation inducing Fas-FasL apoptosis), and ignorance (antigens in immunoprivileged sites behind barriers like blood-brain barrier) Panel B: Regulatory T cell biology showing thymic Treg development from intermediate-affinity self-reactive thymocytes, peripheral iTreg induction by TGF-β, Foxp3 as master transcription factor, and suppressive mechanisms (IL-10, TGF-β, CTLA-4, IL-2 consumption) Panel C: Immune checkpoint pathways showing CTLA-4 competing with CD28 for CD80/86 binding and removing costimulatory molecules, and PD-1 engaging PD-L1/PD-L2 to inhibit T cell effector function, with checkpoint inhibitor antibodies blocking these interactions for cancer therapy Panel D: IPEX syndrome pathophysiology showing FOXP3 mutation preventing Treg development, uncontrolled self-reactive T cell activity, multi-organ autoimmune destruction (enteropathy, diabetes, thyroiditis, dermatitis), and treatment approaches (immunosuppression, HSCT) </image>

Summary

• Adaptive immunity is specific, diverse, self-tolerant, and generates immunological memory
• Primary lymphoid organs (bone marrow, thymus) support lymphocyte development and selection
• Secondary lymphoid organs (lymph nodes, spleen, MALT) are sites of antigen encounter and immune response initiation
• Antigen receptors (BCR/immunoglobulin, TCR) achieve diversity through V(D)J recombination and chain pairing
• Clonal selection: antigen selects specific lymphocyte clones for expansion and differentiation
• Humoral immunity (B cells, antibodies) targets extracellular pathogens; cell-mediated immunity (T cells) targets intracellular pathogens
• Primary response: slow (1-2 weeks), IgM predominant, lower affinity
• Secondary response: rapid (1-3 days), IgG predominant, higher affinity, greater magnitude
• Immunological memory persists through long-lived memory cells maintained by homeostatic cytokines
• Peripheral tolerance involves anergy, deletion, Tregs, and immune checkpoints

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown